Additionally, the 36-month beta value for MIRA is 4.38. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MIRA is 9.52M and currently, short sellers hold a 4.70% ratio of that float. The average trading volume of MIRA on August 26, 2024 was 4.97M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MIRA) stock’s latest price update
The stock price of Mira Pharmaceuticals Inc (NASDAQ: MIRA) has plunged by -1.07 when compared to previous closing price of 1.87, but the company has seen a -4.15% decline in its stock price over the last five trading sessions. accesswire.com reported 2024-08-19 that MIAMI, FL / ACCESSWIRE / August 19, 2024 / MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) “MIRA” or the “Company”), a leading pre-clinical-stage pharmaceutical company, is pleased to provide a comprehensive update on its recent achievements and scientific advancements as it nears a crucial milestone: the submission of its Investigational New Drug (IND) application by the end of the year. This update highlights the company’s strategic progress, significant scientific breakthroughs, and the expertise driving its innovative drug candidates toward clinical trials.
MIRA’s Market Performance
Mira Pharmaceuticals Inc (MIRA) has seen a -4.15% fall in stock performance for the week, with a -39.14% decline in the past month and a 110.23% surge in the past quarter. The volatility ratio for the week is 9.85%, and the volatility levels for the past 30 days are at 15.64% for MIRA. The simple moving average for the past 20 days is -12.31% for MIRA’s stock, with a 39.48% simple moving average for the past 200 days.
MIRA Trading at 27.15% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.67% of loss for the given period.
Volatility was left at 15.64%, however, over the last 30 days, the volatility rate increased by 9.85%, as shares sank -31.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +150.00% upper at present.
During the last 5 trading sessions, MIRA fell by -4.15%, which changed the moving average for the period of 200-days by +30.26% in comparison to the 20-day moving average, which settled at $2.0668. In addition, Mira Pharmaceuticals Inc saw 76.19% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Aminov Erez, who purchase 8,700 shares at the price of $0.94 back on May 21 ’24. After this action, Aminov Erez now owns 382,200 shares of Mira Pharmaceuticals Inc, valued at $8,176 using the latest closing price.
McNulty Brian Patrick, the 10% Owner of Mira Pharmaceuticals Inc, sale 61,331 shares at $3.98 during a trade that took place back on Dec 04 ’23, which means that McNulty Brian Patrick is holding 723,062 shares at $244,097 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -4.38. Equity return is now at value -748.59, with -373.77 for asset returns.
Currently, EBITDA for the company is -8.53 million with net debt to EBITDA at 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.68.
Conclusion
In conclusion, Mira Pharmaceuticals Inc (MIRA) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
